Los Angeles Capital Management LLC Reduces Stock Position in Molina Healthcare, Inc (NYSE:MOH)

Los Angeles Capital Management LLC decreased its position in shares of Molina Healthcare, Inc (NYSE:MOH - Free Report) by 40.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 116,953 shares of the company's stock after selling 79,560 shares during the period. Los Angeles Capital Management LLC owned about 0.22% of Molina Healthcare worth $38,523,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in MOH. South Dakota Investment Council raised its stake in Molina Healthcare by 9.1% during the first quarter. South Dakota Investment Council now owns 7,202 shares of the company's stock worth $2,372,000 after buying an additional 600 shares during the last quarter. Allegiance Financial Group Advisory Services LLC bought a new position in Molina Healthcare during the first quarter worth $335,000. Parcion Private Wealth LLC bought a new position in Molina Healthcare during the first quarter worth $226,000. Victory Capital Management Inc. raised its stake in Molina Healthcare by 13.5% during the first quarter. Victory Capital Management Inc. now owns 160,192 shares of the company's stock worth $52,766,000 after buying an additional 19,008 shares during the last quarter. Finally, Bridgewater Advisors Inc. bought a new position in Molina Healthcare during the first quarter worth $209,000. Institutional investors and hedge funds own 98.50% of the company's stock.

Insiders Place Their Bets

In other Molina Healthcare news, Director Richard M. Schapiro sold 669 shares of the stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total transaction of $214,414.50. Following the completion of the sale, the director owned 11,244 shares of the company's stock, valued at $3,603,702. This represents a 5.62% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the sale, the chief executive officer directly owned 257,715 shares of the company's stock, valued at $82,484,262.90. The trade was a 25.35% decrease in their position. The disclosure for this sale can be found here. 1.26% of the stock is currently owned by corporate insiders.

Molina Healthcare Price Performance

NYSE MOH traded down $21.78 on Friday, hitting $182.47. The stock had a trading volume of 3,589,203 shares, compared to its average volume of 736,452. Molina Healthcare, Inc has a 52-week low of $182.09 and a 52-week high of $365.23. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.63 and a current ratio of 1.63. The company has a market capitalization of $9.89 billion, a price-to-earnings ratio of 8.81, a price-to-earnings-growth ratio of 0.81 and a beta of 0.55. The firm has a 50-day moving average of $281.73 and a 200-day moving average of $300.46.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, topping analysts' consensus estimates of $5.96 by $0.12. The firm had revenue of $11.15 billion for the quarter, compared to analyst estimates of $10.86 billion. Molina Healthcare had a net margin of 2.81% and a return on equity of 28.38%. The business's revenue for the quarter was up 12.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $5.73 EPS. Equities analysts expect that Molina Healthcare, Inc will post 24.4 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the stock. Truist Financial decreased their price target on shares of Molina Healthcare from $400.00 to $335.00 and set a "buy" rating for the company in a research note on Wednesday. Robert W. Baird reaffirmed a "neutral" rating and issued a $375.00 price target (up from $331.00) on shares of Molina Healthcare in a research note on Tuesday, April 15th. Guggenheim started coverage on shares of Molina Healthcare in a report on Wednesday, April 9th. They set a "neutral" rating for the company. Barclays reduced their price objective on shares of Molina Healthcare from $351.00 to $347.00 and set an "equal weight" rating for the company in a report on Monday, June 9th. Finally, Morgan Stanley cut shares of Molina Healthcare from an "overweight" rating to an "equal weight" rating and reduced their price objective for the company from $364.00 to $266.00 in a report on Thursday, July 10th. Eleven investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $347.57.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.